| Financial Year |
September 30 2020 |
| Monetary Funds |
40,257,430.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
853,857,610.33 |
| Advances to Suppliers |
34,440,393.45 |
| Other Receivables |
761,624,787.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,957,093,242.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
109,930,094.20 |
| Total Current Assets |
6,757,203,557.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,132,483.13 |
| Investment Properties |
-- |
| Fixed Assetes |
262,797,862.49 |
| Under-construction Projects |
192,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
365,543,180.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
370,504.95 |
| Deferred Income Tax Assets |
23,005,888.72 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
701,121,919.89 |
| Total Assets |
7,458,325,477.77 |
| Short-Term Loans |
2,980,098,385.84 |
| Trading Financial liabilities |
137,812.55 |
| Notes Payable |
-- |
| Accounts Payable |
318,066,241.38 |
| Accounts Received In Advance |
283,114,019.63 |
| Employee Compensation Payable |
8,255,728.96 |
| Taxes Payable |
126,718,066.69 |
| Interest Payable |
588,897,283.16 |
| Dividend Payable |
35,988,600.75 |
| Other payables |
1,234,634,294.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,297,959,999.84 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
6,248,984,549.28 |
| Long-term Loans |
278,067,373.88 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,909,080.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
287,976,454.03 |
| Total Liabilities |
6,536,961,003.31 |
| Paid-In Capital(Or Share Stock) |
1,488,715,304.00 |
| Capital Surplus |
2,900,929,081.60 |
| Surplus Reserve |
74,432,632.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,596,636,472.87 |
| Minority Stockholder's Interest |
36,440,129.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
884,924,344.89 |
| Owner's Equity（Stockholder's Equity） |
921,364,474.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,458,325,477.77 |
